A review of a number of clinical trials that address the utility of antiplatelet therapy in the primary and secondary prevention of AVF or AVG thromboses. Special attention is paid to the study designs of a number of key clinical trials.







**************************************

Estimated Time to View: 20 minutes
Title: Antiplatelet agents for the prevention of arteriovenous fistula/graft thromboses
Author: Nirav Jasani, MD
Author Type: Fellow
Citation: Nephrology On-Demand 2011
Date Created: 2011
Revisions: None Indicated
Disclaimers: None
Resource Type: Video
Other: Presented at ECU Journal Club on 10/18/11
Recommend to a Colleague/Friend

**************************************

LEARNING OPTIONS:

To view the interactive video, click here
To view this video using an iPad or iPhone, see below




Transparent Peer Review



GD Star Rating
loading...



To learn more about our 6-point transparent peer review system, click here



Share

Comments

More in Arteriovenous Fistula, Arteriovenous Graft, Vascular Access (3 of 19 articles)